The immune system must constantly monitor the gastrointestinal tract for the presence of pathogens while tolerating trillions of commensal microbiota. It is clear that intestinal microbiota actively modulate the immune system to maintain a mutually beneficial relation, but the mechanisms that maintain homeostasis are not fully understood. Recent advances have begun to shed light on the cellular and molecular factors involved, revealing that a range of microbiota derivatives can influence host immune functions by targeting various cell types, including intestinal epithelial cells, mononuclear phagocytes, innate lymphoid cells, and B and T lymphocytes. Here, we review these findings, highlighting open questions and important challenges to overcome in translating this knowledge into new therapies for intestinal and systemic immune disorders.
The intestinal microbiota contributes to health and disease in the gut, and beyond Advances in 16S ribosomal RNA sequencing have revealed the intestinal microbiota to be an incredibly complex community, comprising thousands of bacterial species in humans that vary markedly in distinct regions of the intestinal tract [1, 2] . Although every human harbours a unique microbiota, there is a common pattern at the phyla level, with Bacteroidetes and Firmicutes (dominated by Clostridia) being the most abundant [2] . Novel metagenomic approaches have further clarified the composition of the microbiota, which will be useful in identifying the potential roles of distinct bacteria in intestinal homeostasis [3, 4] .
Fundamental roles of the microbiota in mammalian physiology have been derived from studies of germ-free (GF) or antibiotic-treated animals, demonstrating that the microbiota aids in food digestion, nutrient supply, and resistance to pathogenic infection [2] . Furthermore, GF animals exhibit impaired immune development, characterised by immature gut-associated lymphoid tissues (GALT), decreased numbers of intestinal lymphocytes, and diminished levels of antimicrobial peptides and immunoglobulin (Ig) A, all of which are reversed upon colonisation with commensal bacteria [5] . Additionally, maturation of the immune system appears dependent on host-specific commensals, because it did not occur in GF mice colonised with human microbiota [6] , although this was recently challenged by the finding that selected species of human microbiota induced a population of regulatory T cells (Tregs) in the intestine of GF mice [7, 8] . Despite promoting GALT development, not all members of the intestinal microbiota are beneficial; some may act as opportunistic pathogens, overabundance of certain commensals may predispose to pathogenic infection [9] , and antibiotic-mediated alterations in commensal microbiota can predispose to nosocomial infections [10] . Interactions with intestinal microbiota may even facilitate infection by other enteric pathogens, as has been demonstrated for certain viruses and parasites (Box 1).
Furthermore, accumulating evidence suggests a correlation between inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, and altered microbiota, a state termed 'dysbiosis', although whether dysbiosis is a primary cause of IBD or arises as a consequence of chronic intestinal inflammation remains unclear [11] . Nevertheless, in individuals with predisposing genetic or environmental abnormalities, intestinal microbiota are the focus of the aberrant host immune responses that drive the chronic inflammation characteristic of IBD [11] . An important caveat of many experimental studies linking dysbiosis to disease susceptibility in particular genotypes is the demonstration that familial transmission of microbiota from mother to neonate can have a dominant role in conferring distinct microbiotas (Box 2).
More recently, it has become clear that the influence of the microbiota extends beyond the intestinal tract and affects the systemic immune system. For instance, GF mice exhibited resistance to experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), but disease susceptibility was restored upon colonisation with microbiota, or by monocolonisation with segmented filamentous bacteria (SFB) [12] [13] [14] . Another interesting finding linked intestinal microbiota to genderdependent susceptibility to type 1 diabetes mellitus (T1DM) in the nonobese diabetic (NOD) mouse model [15] . Female NOD mice are more susceptible to T1DM than are males, a phenotype that is equalised under GF settings. Moreover, transfer of caecal contents from male into female NOD mice corrected the susceptibility in a manner that was dependent on androgen receptor signalling and correlated with increases in testosterone levels [15] . Further implicating a role for the microbiota in metabolic disease, shifts in microbiota composition were recently associated with the progression of the liver disorder nonalcoholic steatohepatitis (NASH) [16] . Thus, mice deficient in the inflammasome-associated, cytosolic innate immune receptors NOD-like family, pyrin domain containing (NLRP) 3 or NLRP6, displayed exacerbated NASH that was due to a dysbiotic microbiota, because wild type mice cohoused with the inflammasome-deficient mice also showed increased susceptibility to NASH [16] . Additional examples of the influence of intestinal microbiota on autoimmune disorders include studies in mouse models of inflammatory arthritis and autoimmune polyglandular syndrome [17] .
Together, these studies highlight that the microbiota have a wide range of effects on the development and responsiveness of the local and systemic immune system, but the mechanisms responsible are incompletely understood. Here, we review recent progress that has begun to elucidate some of the cellular and molecular factors involved. We outline how structural moieties and metabolites derived from the intestinal microbiota act on intestinal epithelial cells (IEC) and local innate leukocytes to maintain barrier defence and regulate immune homeostasis. We then describe how microbiota-derived factors activate a multitude of pathways that control adaptive immunity in the gut, by promoting IgA secretion and regulating the balance between effector and regulatory T cells. Finally, we note some of the key issues that remain to be addressed to translate this improved understanding into novel treatments for infections and inflammatory diseases.
Sensing of microbiota by IECs maintains intestinal homeostasis IEC form a single cell barrier layer on the surface of the intestinal mucosa and, although not considered bona fide immune cells, their interactions with intestinal microbiota influence the immune response and have a crucial role in maintaining homeostasis [18] .
Box 1. Exploitation of intestinal microbiota by enteric viruses and helminths
Intestinal microbiota affect the ability of the host to deal with other classes of pathogen, given that GF mice show enhanced susceptibility to many infections [130] . More recent studies have provided insight into some of the mechanisms involved. Antibiotic treatment to deplete intestinal microbiota revealed that tonic stimulation of innate immune circuits by the microbiota enhanced protective adaptive immune responses to influenza virus infection in the respiratory tract and to systemic infection with lymphocytic choriomeningitis virus [131, 132] . Conversely, other studies show that some enteric viruses exploit the commensal microbiota to promote infection. The retrovirus, mouse mammary tumor virus (MMTV), is transmitted to neonatal mice in the milk of infected mothers; however, ablation of the intestinal microbiota prevented MMTV transmission to the offspring [133] . Furthermore, MMTV bound microbiota-derived LPS forming a complex that triggered TLR4-dependent IL-10 secretion by myeloid cells, engendering tolerance towards the virus to facilitate transmission [133] . Similarly, antibiotic-mediated depletion of microbiota induced resistance to enteric infection with reovirus and poliovirus [134] . Mechanistically, binding of bacterial LPS enhances poliovirus infectivity by increasing virion stability and by enhancing binding to the poliovirus receptor [135] . Furthermore, the reactivation of pathogenic endogenous retroviruses observed in antibody-deficient mice was dependent on the presence of the microbiota [136] . These studies reveal new aspects of the influence of the microbiota on viral infections and suggest that the use of antibiotics and probiotics during viral infections should be carefully considered.
Recently, Iliev et al. performed high-throughput sequencing to define the mouse intestinal fungal 'mycobiome', containing over 200 fungal species [137] . Furthermore, they found that mice deficient in Dectin-1, a key PRR that senses fungal b-glucans, exhibited greater susceptibility to DSS-induced colitis that was attenuated by treatment with an antifungal drug [137] . Finally, they identified a single nucleotide polymorphism (SNP) in Dectin-1 (CLEC7A) that was associated with more severe ulcerative colitis in humans [137] . Thus, impaired immunity to commensal fungi may exacerbate pathological inflammatory responses in the gut, but the mechanisms involved remain to be identified.
A key component of the intestinal fauna with which mammals have coevolved are multicellular parasites, especially helminth worms that frequently colonise the gastrointestinal tract [138] . Helminth infections, or treatment with the immune suppressive factors that they produce, can inhibit various immunopathological disorders, including models of IBD [138] . Intestinal helminths may indirectly regulate immune responses against intestinal microbiota through 'bystander' immune suppression. In addition, mice infected with the parasitic nematode Heligmosomoides polygyrus had altered ileal microbiota composition [139] . Conversely, commensal bacteria may in some cases have a critical role in facilitating infection by metazoan parasites. Contact with intestinal microbiota was shown to promote hatching of eggs of the mouse intestinal nematode Trichuris muris and antibiotic-mediated depletion of the microbiota resulted in reduced worm burdens [140] . Thus, interactions with intestinal microbiota appear to trigger the parasite to hatch in the appropriate niche and type I fimbriae were shown to be capable of mediating this interaction [140] .
Finally, in addition to interactions with other classes of pathogen, much remains to be discovered regarding how interspecies interactions amongst the bacterial microbiota may impact on intestinal homeostasis (see the review by Kaiko and Stappenbeck in this issue [141] ). Therefore, within the complex environment of the gut, both host-microbe and microbe-microbe interactions can profoundly influence local and systemic immune homeostasis.
Box 2. A cautionary note on microbiota associations with genotype and disease susceptibility Although a plethora of studies have implicated microbiota dysbiosis with increased disease phenotypes in transgenic mice [142] , such as those deficient in PRR signalling, a key study highlighted the risk of potential false positive associations in these types of investigation. Ubeda et al. showed that Myd88 À/À and Tlr À/À mice exhibited distinct microbiotas from each other, but that these were primarily shaped by maternal transmission rather than host genotype [143] . Thus, by crossing heterozygous Myd88 +/À mice or Tlr +/À mice to generate wild type and knockout mice from the same litter, they demonstrated that there was little difference in the intestinal microbiota composition of wild type and TLR-deficient littermates [143] . Indeed, the microbiota of wild type littermates more closely resembled that found in their Myd88 À/À littermates than that present in wild type mice from other colonies [143] . Thus, some of the reported incidences of 'dysbiosis' between wild type and knockout mouse strains may in fact reflect divergence of microbiota that occurs during long-term breeding of isolated colonies, which is perpetuated by maternal transmission. This elegant study shows that littermate controls are crucial in differentiating between dysbiosis that may emerge stochastically and dysbiosis that is causally related to the genotype of the host and, therefore, should be used in future studies in this area.
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Trends in Immunology November 2014, Vol. 35, No. 11 Commensal bacteria influence the epithelial barrier in a multitude of ways. Sensing of bacterial metabolites and structural components by IEC fortifies barrier integrity and protects from pathogen invasion [18] . For example, IEC sensing of commensals through toll-like receptors (TLRs) protects from epithelial injury following administration of dextran sulphate sodium (DSS), in part, by regulating the secretion of cytoprotective factors [interleukin (IL)-6, tumour necrosis factor (TNF)-a, keratinocyte chemokine-1 (KC-1), and heat shock proteins] [19] . Recent studies further underlined the crucial role of pattern recognition receptor (PRR) activation in the intestinal epithelium, with NLRP3 inflammasome-mediated IL-18 production exerting protective effects against DSS-induced colitis and colon cancer [20, 21] . Although these studies highlight beneficial tissue-protective effects of the microbiota, chronic activation of IEC by a dysbiotic microbiota can exacerbate colon carcinogenesis by driving IL-17C production from IEC that acts in an autocrine fashion to inhibit apoptosis [22] .
Apart from providing important energy sources for the intestinal epithelium, commensal metabolites also promote IEC homeostasis. Short chain fatty acids (SCFA), such as acetate, butyrate, and propionate, which are generated by microbiota-mediated processing of dietary fibre and nondigestible carbohydrates, are important mediators in the communication between microbiota and IEC. For instance, microbiota-derived butyrate signals through the G protein-coupled receptor (GPR) 109A to induce IL-18 expression in IEC and this inhibited colitis-associated colon cancer (CAC) [23, 24] . The protective effects of butyrate-producing microbiota are emphasised by findings that these bacteria are reduced in patients with IBD [25, 26] . Other work identified a role for Bifidobacterium-derived acetate in promoting antiapoptotic responses in IEC, resulting in reduced mortality following challenge with enterohaemorrhagic Escherichia coli infection [27] . Thus, microbiota-derived SCFA can have multiple protective effects on IEC following infection or insult ( Figure 1 ).
To bolster the epithelial barrier, specialised IEC known as goblet cells synthesise mucins that form a 150 mm-thick protective mucus gel, which covers the intestinal epithelium and is augmented with IEC-derived antimicrobial peptides (AMPs) [28] . In the colon, the mucus layer is divided into two zones: an inner dense layer that is firmly attached to the apical surface of IEC and is usually sterile, and a loose outer layer that provides a niche for certain commensals [28] .
In animal models, defects in the mucus layer, such as genetic ablation of the major mucin MUC2, allow increased contact of commensal bacteria with IEC and lead to spontaneous colitis and colon cancer, emphasising the importance of an intact mucus barrier in maintaining intestinal homeostasis [29] [30] [31] . Moreover, reduced mucus secretion is a common feature of human IBD, although it is again unclear whether this is a primary cause or a secondary consequence of the inflammatory setting [32] . Two recent studies raised the intriguing possibility that mucus also promotes tolerogenic responses to food and commensal antigens [33] . Thus, MUC2, through interactions with galectin-3 and Dectin-1, conditioned dendritic cells to produce factors such as transforming growth factor (TGF)-b, IL-10 and retinoic acid (RA) that promote forkhead box P3 (Foxp3) + Treg cell induction [33] . In addition, goblet cells themselves have been proposed to promote intestinal tolerance by delivering luminal antigens to CD103 + dendritic cells, although whether this transport required interactions of such antigens with mucus was not determined [34] . However, further studies are required to ascertain the biological significance of antigen interactions with goblet cells and mucus and to determine whether these processes have an essential role in the induction of tolerance to intestinal antigens. Finally, given that degradation by some commensal species may influence the structure of the mucus layer [35, 36] , it is possible that the composition of microbiota also modulate functions of the host mucus.
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Whereas some AMPs, such as a-defensins, are constitutively expressed by IEC, secretion of others is regulated by sensing of commensal-derived pathogen-associated molecular patterns (PAMPs) [37] . Reg3g, an inducible AMP, was recently shown to have a crucial role in establishing spatial segregation between commensal bacteria and the host epithelium [38] . Thus, mice lacking Reg3g, or lacking MyD88 expression in IEC, lost the 50-mm sterile inner mucus layer that segregates the microbiota from the epithelium, displayed higher faecal IgA levels and increased frequencies of intestinal interferon (IFN)-g + CD4 + T cells [38] . The production of Reg3g by IEC is directly induced by microbiota because oral administration of lipopolysaccharide (LPS) induced expression of Reg3g only when TLR4 was expressed in nonhaematopoietic cells (i.e., IEC) [39] ( Figure 1 ). In addition to bactericidal activity, AMPs can exert modulatory functions on chemotaxis, TLR signalling and wound healing [40] . For example, expression of Reg3g is increased in damaged mucosae and may regulate IEC proliferation [41] .
IEC contribute to mucosal immune tissue development in response to the microbiota. Peptidoglycan derived from the cell wall of commensal bacteria activates the cytoplasmic PRR NOD1 in IEC and induces b-defensin 3 and CCL20 secretion, which drive formation of isolated lymphoid follicles (ILFs) [42] . IEC also influence recruitment, activation, and differentiation of immune cells by secretion of a variety of modulatory factors in response to commensal microbiota, including; thymic stromal lymphopoetin (TSLP), TGF-b, prostaglandin E2, RA, and IL-25 [2] . For example, production of TSLP by IEC inhibits the secretion of IL-12/23p40 by CD11c + CD11b + dendritic cells, thus limiting pro-inflammatory Th1 and Th17 responses and promoting Th2 responses [43] . In addition, some commensal Clostridium species can promote the differentiation and function of colonic Treg cells, by increasing production of the active form of TGF-b [44] (Figure 2) . Indeed, Clostridium species were shown to enhance expression of molecules that convert latent TGF-b into its active form by IEC, such as matrix metalloproteinases (MMPs) [44] . However, more recent studies have linked the induction of TGF-b by Clostridium species to their production of SCFA, such as butyrate [7] , which, as we discuss later, may also act directly on T cells to promote Foxp3 + Treg cell differentiation [45] . [46, 47] . CD103 + DC are crucial in promoting oral tolerance against food antigens [48] . Acquisition of the Foxp3 + Treg cell programme can occur during development in the thymus (nTregs), or may be induced in peripheral locations (iTregs) [49] , including the intestine. CD103
+ DC promote iTreg cell differentiation in the MLN through secretion of RA and TGF-b [50] [51] [52] and by integrin avb8-mediated conversion of latent TGF-b into its active form [53] . Furthermore, secretion of RA by CD103 + DC also primes T cells and B cells to express the gut-homing receptors a4b7 and CCR9 [54] . Conversely, CX 3 CR1 + MP are thought to be nonmigratory, and can sample intestinal luminal contents by extending dendrites through the epithelium and may be involved in the secondary expansion of Foxp3 + Treg cells in the lamina propria (LP), which were primed initially in gut-draining lymph nodes [55, 56] . This may be mediated via IL-10 production, because IL-10 secretion from iMP is required to maintain Foxp3 expression in Treg cells [57] . Interestingly, CX 3 CR1 + MP may also promote oral tolerance through the transfer of soluble food antigens to CD103 + DC via gap junctions, to facilitate iTreg induction by CD103 + DC [58] . Intestinal bacteria can directly modulate local iMP functions to regulate effector T cell responses in the gut, particularly Th17 CD4 + T cells, which are crucial for defence against extracellular pathogens. For example, ATP produced by commensal bacteria activates CX 3 CR1 + MP and leads to the induction of Th17 cells in a MyD88-independent manner, suggesting that TLR signalling is dispensable [59] (Figure 2) . Nevertheless, in other settings, ATP also acts on P2X7 purinergic receptors to activate the NLRP3 inflammasome that leads to IL-1b secretion [60] , suggesting that NLR sensing potentiates
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Th17 differentiation. Indeed, recent studies by Shaw et al. revealed that commensal-derived signals induced IL-1b production from iMP that was essential for the induction of small intestinal Th17 cells under homeostatic conditions [61] . However, conversely, the same group showed that iMP in the colonic LP produced IL-1b only in response to NLRC4-triggering pathogens but not to commensals [62] . This discrepancy may reflect the different environmental factors and distinct microbiota found in the small and large intestine. Furthermore, additional studies are required to decipher the role of direct microbial sensing by iMP, versus potential conditioning effects of IEC-derived factors, in IL-1b secretion by iMP in different intestinal locations. In models of bacterially triggered IBD, IL-1b exacerbated pathology by promoting accumulation of IL-17-producing innate and adaptive leukocytes [63] . These findings parallel previous reports on IL-23, which is also produced by iMP in response to intestinal bacteria to boost local Th17 responses [64] . Indeed, IL-23 and IL-1b act synergistically to potentiate innate and adaptive Th17 responses in the gut [63] . Thus, the kinetics and context of iMP-derived IL-23 and IL-1b secretion may determine whether Th17 cells meditate protective or pathogenic effects.
GF mice harbour reduced frequencies of intestinal Th17 cells, which were restored upon monocolonisation with SFB, although this effect was mostly limited to small intestinal Th17 cells. [65, 66] . It was proposed that SFB colonisation increased levels of the acute-phase protein serum amyloid A (SAA), which conditioned CD11c + MP to prime Th17 cells [66] . However, recent studies reported that presentation of SFB antigens on MHC II molecules by LP CD11c + DC led to the induction of SFB-specific intestinal Th17 cells [67] [68] [69] . It is possible that SFB also modulate immune responses using other mechanisms, because recent genome sequencing of SFB revealed that they might produce SCFA [70] [71] [72] , although whether this is of functional relevance remains to be established. However, others contend that SFB-induced Th17 cells may not constitute bona fide mutualistic Th17 cells, but rather represent a pathogenic subset [73] , and whether SFB (or an equivalent) are present in humans remains unknown. Together, these studies suggest that microbial effects on distinct iMP populations underlie the differential induction of Th17 and iTreg cells in the gut (Figure 2 ). Clostridium species belonging to clusters IV, XIVa, and XVIII induce TGF-b production in IEC, which promotes Treg cell differentiation in the colon.
Trends in Immunology November 2014, Vol. 35, No. 11 are enriched in mucosal tissues and, based on phenotype and function, have been classified into three subgroups: ILC1, ILC2, and ILC3 [74] . ILC3 cells have important roles in the containment of commensals and in protective immune responses against enteric pathogens. ILC3 are the major innate source of IL-22 in the lamina propria, which limits systemic dissemination of commensals [75] . IL-22 signals through IL-22R on IEC to drive signal transducer and activator of transcription 3 (STAT3) activation and induction of AMPs, including Reg3g and Reg3b, that protect against enteric pathogens, such as Citrobacter rodentium [76] [77] [78] . A recent study suggested that ILC also have a role in the maintenance of CD4 + T cell tolerance towards the commensal microbiota, because some were shown to express major histocompatibility complex (MHC) II and were capable of antigen presentation [79] . ILC3 do not express co-stimulatory molecules and appear to limit T cell responses, because deletion of MHCII specifically on RORgt + ILC resulted in spontaneous T cell-mediated intestinal inflammation [79] . In contrast to these protective activities, excessive ILC activation can drive chronic intestinal inflammation and CAC [80, 81] . In these models, ILC respond to IL-23 to produce high levels of IFN-g, IL-17, and IL-22 that are pathogenic [80, 82] .
Although numerous studies have shown the microbiota to be dispensable for the development of most ILC [82] , NCR + RORgt + ILC are reduced in GF or antibiotic-treated mice [83] [84] [85] . Commensals may regulate ILC either through direct recognition, or indirectly through the induction of cytokine secretion by other cells. For example, human RORgt + ILC directly respond to TLR2 agonists by secreting IL-2, which acts in an autocrine manner to induce IL-22 expression [86] . By contrast, systemic administration of flagellin triggers TLR5 on lamina propria iMP, resulting in secretion of IL-23 that enhances IL-22 production by RORgt + ILC, leading to Reg3g release from IEC [87] [88] [89] (Figure 1 ). Conversely, another study reported that RORgt + ILC constitutively produce IL-22, but that this is repressed by microbiota-driven IL-25 production from IEC [90] . A recent study revealed that ILC also interact cooperatively with iMP to regulate intestinal homeostasis [91] . Thus, steady-state sensing of microbiota by intestinal macrophages drives IL-1b release, which in turn induces ILC3 to produce granulocyte-macrophage colony stimulating factor (GM-CSF). ILC3-derived GM-CSF triggers DC and macrophages to produce IL-10 and RA that promote Treg expansion in the intestine, and ablation of production by ILC3 impaired tolerance induction to dietary antigen [91] . However, whether ILC3-mediated GM-CSF production has any role in Treg cell-mediated tolerance towards the intestinal microbiota remains to be determined.
Dietary compounds, such as phytochemicals derived from the catabolism of cruciferous vegetables, may also influence ILC function through activation of the aryl hydrocarbon receptor (Ahr) [92] . Indeed, Ahr À/À mice harbour reduced frequencies of NKp46 + ILC3, and have impaired IL-22 production [93, 94] . In addition, Ahr expression on RORgt + ILC is essential for isolated lymphoid follicle (ILF) maturation [95] . Mechanistically, signalling through Ahr promoted ILC survival by reducing apoptosis and enhanced IL-22 production by binding to the IL-22 locus in synergy with RORgt [94] . Recent studies have uncovered how the microbiota regulates Ahr ligand availability and associated protective immunity. Mice fed tryptophanenriched diets, displayed an outgrowth of particular Lactobacillus species that were able to utilise tryptophan as an energy source [96] . Tryptophan degradation by these Lactobacillus spp. generated the metabolite indole-3-aldehyde, an Ahr ligand that promotes IL-22 transcription by ILC3, which confers colonisation resistance against Candida albicans [96] . Another recent study showed that mice lacking Ahr in RORgt + ILC3 exhibited a pronounced susceptibility to spontaneous intestinal inflammation, which was associated with an outgrowth of SFB and accumulation of IFNg + IL-17 + CD4 + T cells [97] . Thus, Ahr-mediated regulation of IL-22 secretion by ILC3 may be important in preventing dysbiosis-driven intestinal inflammation.
Overall, these studies illustrate that ILC can not only regulate the microbiota to maintain intestinal homeostasis, but also have a key role by responding to signals from other cells that have sensed environmental perturbations induced by microbiota.
Microbiota stimulate multiple pathways to drive secretory IgA production
IgA constitutes approximately 75% of the total antibody production in mammals and the most abundant immunoglobulin in mucosal secretions is dimeric secretory IgA [98] . Studies in GF mice established that commensal bacteria are strong inducers of secretory IgA production, which is an important regulator of microbiota composition and of host exposure to intestinal bacteria [98] . For example, intestinal IgA production induced in response to orally administered flagellin abrogated systemic activation of flagellin-specific CD4 + T cells [99] . Production of IgA in response to microbiota requires a high dosage of bacteria to be induced, but at the same time is very persistent [100] . In addition, it is flexible, because IgA specificity can rapidly change in response to shifts in microbiota composition [100] . Furthermore, a proportion of gut-residing IgA + plasma cells can acquire 'myeloid-like' phenotypic and functional properties in response to microbial stimulation, such as expression of TNFa or inducible nitric oxide synthase (iNOS) [101] . These 'multi-functional' IgA + plasma cells contributed to host protection against C. rodentium, and mice lacking TNFa and iNOS expression in B cells exhibited reduced IgA production and an altered microbiota [101] . Thus, IgA + B cells may influence the microbiota through production of IgA or through elaboration of antimicrobial factors.
Development of gut-resident B cells can also be influenced by the microbiota. Although the early stages of B cell development primarily occur in the bone marrow, a recent study found that, around the time of weaning, the intestinal LP contains a population of immature B cells that express Rag recombinase and undergo V(D)J recombination and B cell receptor editing [102] . Importantly, early B cell development in the intestine is promoted by commensals, because GF weanling mice had significantly [102] . These surprising findings might have implications not only for immunoglobulin repertoire diversification at mucosal sites, but also for establishing tolerance against commensal antigens during initial colonisation.
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Class switch recombination to IgA occurs mainly in mucosal-associated lymphoid tissues, including Peyer's patches (PPs), isolated lymphoid follicles and MLNs, through T cell-dependent or independent mechanisms [98] . In the T cell-independent pathway, commensal bacteria induce IEC and iMP to secrete cytokines, such as B cell activating factor of the TNF family (BAFF), a proliferation-inducing ligand (APRIL), and TGF-b, that promote IgA switching [98] . Some species of microbiota are more efficient in inducing an IgA response, due to their closer contact with the intestinal epithelium, such as SFB [98] . Presentation of commensal bacteria antigens by CD103 + DC in the MLNs induces an IgA response [103] . In addition, follicular dendritic cells (FDC), stromal cells that are crucial organisers of B cell follicles and germinal center (GC) formation, can also support class switching to IgA in PPs, by secreting BAFF and TGF-b following stimulation by TLR and RA receptor agonists present in the intestinal environment [104] . Recent studies also identified a role for ILC in the induction of intestinal IgA, by providing distinct forms of the cytokine lymphotoxin [105] . Thus, ILC-derived soluble LT (LTa 3 ) promotes T cell homing to the intestine to facilitate T cell-dependent IgA responses, whereas membrane-bound LT (LTa 1 b 2 ) on ILC is critical for T cellindependent IgA responses, probably by regulating local DC activation [105] . Taken together, these studies indicate that a variety of stromal cells and innate leukocytes can contribute to microbiota-induced intestinal IgA production ( Figure 2) . Foxp3 + Treg cells have been implicated in T cell-dependent IgA production, because transfer of Treg cells into T cell-deficient mice restored intestinal IgA secretion through provision of TGF-b [99] . Consistent with these findings, Foxp3 + Treg cells can differentiate into follicular helper T (Tfh) cells in the PPs [106] . However, these observations were recently challenged by fate-mapping studies that demonstrated that a large proportion of (Tfh) cells in PPs were derived from Th17 cells and not from Treg cells [107] . Furthermore, mice defective in IL-17R signalling have reduced expression of the intestinal polymeric Ig receptor (pIgR), and lower levels of intestinal IgA [108] and Th17-derived (Tfh) cells were crucial for the induction of T cell-dependent intestinal IgA responses against cholera toxin [107] . The plasticity between Treg, Th17 and (Tfh) cells in the gut requires further investigation, but given that different species of microbiota are potent inducers of Treg or Th17 cells, they might modulate T cell-dependent intestinal IgA production.
In terms of how intestinal IgA regulates microbiota composition, AID G23S transgenic mice, which harbour a point mutation in the enzyme activation-induced cytidine deaminase (AID), resulting in a defect in somatic hypermutation (SHM) but not in class switch recombination, enabled selective evaluation of the role of SHM in mucosal homeostasis [109] . Although mice unable to undergo SHM had normal levels of intestinal IgA and IgA + B cells, they exhibited pronounced GC B cell hyperplasia in PPs, which was accompanied by outgrowth of microbiota in the small intestine, and had increased susceptibility to oral challenge with Yersinia enterocolitica and cholera toxin [109] . Furthermore, mice lacking the inhibitory co-receptor PD-1, a key regulatory molecule expressed by (Tfh) cells, accumulated dysfunctional (Tfh) cells in the GC of the PPs, which led to dysregulated selection of IgA + B cells and an altered repertoire of intestinal IgA with reduced bacteriabinding capacity [110] . This in turn caused marked dysbiosis in PD-1-deficient mice [110] . Together with the reversible monocolonisation study by Hapfelmeier et al. [100] , these reports underline the role of constant stimulation by microbiota for the induction of SHM in IgA + B cells in the PP GCs that maintains diversified, high-affinity IgA secretion and a balanced humoral response against commensals.
Sensing microbiota through innate signalling pathways is important in several aspects of systemic B cell responses. The lack of systemic antibody responses against the intestinal microbiota is considered a sign of well-maintained sequestration of commensals and mucosal homeostasis [98] , but it proves to be beneficial in the absence of innate immune protection [111] . Furthermore, Kirkland et al. observed that B cell intrinsic MyD88 signalling was required to provide protection from microbial dissemination following DSS-induced intestinal damage, through influencing IgM, but not IgA production [112] . Similarly, in Myd88-deficient mice, protection from bacteraemia caused by commensal bacteria was provided by systemic T celldependent IgG production directed against commensal antigens [113] . Recently, Rauch et al. identified a new subset of innate response activator (IRA) B cells, derived from B1a cells, that produce GM-CSF and contribute to protection from septic shock [114] . Although IRA B cells depend on MyD88 signalling for their differentiation and expanded in response to LPS, they secreted IgM but not IgA [114] ; therefore, further studies are required to assess their potential role in intestinal homeostasis.
Microbiota shape the differentiation and functions of intestinal T cells
The intestine is populated by a large number of T lymphocytes that perform various regulatory and effector functions [2] . Much recent interest has focussed on how the microbiota modulate the balance among CD4 + T cell subsets and several examples of how commensal bacteria may indirectly influence Th17 and Treg cell induction, through conditioning of iMP and IEC, have been discussed above [33, 44, 59, 61, [66] [67] [68] [69] 73] . In addition, T cells may also express PRR that allow them to sense and respond directly to microbial constituents. For example, cell-intrinsic TLR2 signalling potentiated Th17 differentiation and pathogenic effector responses [115] . Similarly, gd T cells, which are enriched in the intraepithelial lymphocyte population (IEL) and are an important source of innate IL-17 production, can also directly respond to TLR2 agonists [116] . Furthermore, commensal bacteria modulate the abundance and activation status of gd T cells, because GF mice or mice treated with antibiotics have fewer IL-17-producing gd T cells in the intestine [117] . Another study reported
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Trends in Immunology November 2014, Vol. 35, No. 11 that gd + IEL can produce AMPs in response to intestinal bacteria that penetrate the epithelial barrier; however, sensing of bacteria in this case required activation of MyD88 signalling in IEC [118] . In addition, the abundance of IEL was also shown to be regulated by activation of Ahr, because Ahr À/À mice did not maintain IEL and had increased commensal loads in the small intestine [92] . These results, together with a study showing that Ahr signalling is required for ILC-driven isolated lymphoid follicle formation [95] , highlight crucial links between diet, mucosal immune maturation, and microbiota, because, in both cases, vegetable-derived ligands of Ahr mediated the reported immunomodulatory effects [92, 95] . The influence of commensals has also been extended to encompass invariant natural killer T cells (iNKT), by work showing that exposure to commensal microbiota during the neonatal period limits the accumulation of iNKT cells at mucosal sites [119] . Lack of commensal exposure during early life resulted in adult mice exhibiting increased mortality to oxazolone-induced colitis (an iNKT-dependent disease) and increased susceptibility to allergic asthma [119] . Mechanistically, the inhibition of colonic iNKT cell development by commensal microbiota may at least in part be mediated by the interaction of iNKT cells with commensalderived inhibitory sphingolipids [120] (Figure 1 ). Collectively, these findings illustrate that the microbiota have extensive and long-lasting effects on the development and activation of both innate and adaptive T cell populations in the gut.
How commensals influence Foxp3 + Treg cell induction has remained poorly understood, but recent findings have shed new light on this process (Figure 2) . The capsular polysaccharide A (PSA) of the Gram-negative anaerobic commensal Bacteroides fragilis can promote IL-10-producing Foxp3 + Treg cells [121] through direct interaction with TLR2 on T lymphocytes [122] , or indirectly through TLR2-dependent conditioning of DC [123, 124] . Moreover, recent reports presented compelling evidence that SCFA metabolites derived from commensal microbiota, particularly butyrate, can directly induce the differentiation of intestinal Foxp3 + iTreg [45, 125, 126] . Mechanistically, butyrate appeared to promote iTreg induction by inhibiting histone deacetylases (HDAC), because butyrate-treated naive CD4 + T cells exhibited increased acetylation of the Foxp3 locus, including the key CNS1 enhancer region that is essential for iTreg differentiation [45, 125, 126] . A key question in immunology is how the immune system discriminates between commensals and pathogens, because both express similar PAMPs. These new data suggest that SCFA metabolites serve as a 'surrogate for symbiosis', a signal that enforces homeostasis and tolerance towards beneficial commensal microbiota.
The iTreg-promoting activities of commensal metabolites fit well with a previous study that reported that Foxp3 + iTreg cells in the LP expressed a unique subset of T cell receptors (TCRs) that recognised epitopes derived from commensal microbiota [127] . Furthermore, the TCR repertoire in Foxp3 + iTreg cells was distinct from those expressed by naïve and effector CD4 + T cells in the LP, suggesting that exposure to some commensal antigens preferentially directs naïve CD4 + T cells to differentiate into iTreg cells [127] . However, a recent report challenged the concept that locally induced iTreg have a dominant role in maintaining tolerance towards the intestinal microbiota [128] . Thus, single cell, high-throughput sequencing revealed that most TCRs expressed by colonic Foxp3 + Treg cells were shared with the thymic Foxp3 + Treg population, including many TCR that were able to recognise microbiota-derived antigens [128] . In addition, analogous to the flexible IgA responses described above, manipulation of the microbiota composition with antibiotics resulted in alterations in the TCR repertoire of colonic Foxp3 + Treg cells [128] . Although differences in methodological approach might have contributed to the conflicting results regarding the ontogeny of microbiota-specific intestinal Treg cells, the current evidence suggests that the microbiota shape the pool of intestinal Treg cells in at least two ways; by providing factors that promote the de novo differentiation of iTreg and by providing antigenic peptides that stimulate particular clones of thymically derived nTreg cells.
Concluding remarks
The studies discussed here illustrate the diverse mechanisms through which commensal microbiota contribute to the development, maturation, and regulation of the host immune system. They highlight the complex and dynamic nature of host-microbiota interactions and illustrate that immune responses are regulated at several levels by the microbiota. The first of these involves sensing of microbiota constituents and metabolites by IEC and iMP, which, under steady-state conditions, helps maintain intestinal barrier function and conditions iMP to favour regulatory responses. On the next level, resident ILC remain poised to respond to perturbations in intestinal immune homeostasis, by rapidly detecting cytokines released by IEC and iMP during stress or infection. However, microbiota can also directly influence ILC function by producing metabolites that serve as Ahr ligands. Similarly, at the level of adaptive immunity, the unique range of T and B cell responses observed in the gut are not only due to conditioning factors produced by IEC and local iMP, but also reflect direct effects of microbiota antigens and metabolites. Thus, a common theme to emerge is that microbiota can regulate the immune and inflammatory responses of diverse cellular compartments in the gut both directly and indirectly, and extensive interactions between these cells facilitate coordinated, flexible responses to different conditions or infections.
Recent progress has facilitated a conceptual shift in understanding immune-microbe interactions in the gut, expanding the focus beyond PRR sensing of PAMPs, to incorporate the effects of microbial metabolites. The identification of regulatory metabolites, such as SCFA, the key commensal bacteria that produce them, and insights into the molecular pathways involved, offer new possibilities for targeting intestinal diseases such as IBD. However, several challenges remain before the translational potential of this new knowledge can be realized. The pleiotropic effects of microbiota metabolites, such as SCFA, make it desirable that strategies be developed to allow efficient, targeted delivery to the relevant cell type, for example, IEC versus lamina propria T cells. In addition, the synergistic
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Although beyond the scope of this review, characterisation of host microbiota composition in healthy and diseased individuals continues apace, and should further inform the development of novel treatment regimes. For example, heterologous fecal microbiota transplant (FMT) has already demonstrated efficacy for the treatment of recurrent Clostridium difficile infections, although the precise components of the microbiota responsible remain to be determined [129] . Additional advances in this area, when merged with the improved molecular understanding derived from experimental studies described above, should allow the identification of a new generation of beneficial commensal species in humans. However, therapeutic administration of defined microbiota may be dependent on overcoming several technical limitations, including establishing new culture techniques to enable growth and selection of beneficial species, as well as devising protocols to ensure efficient delivery and, when desired, long-term persistence in the gut. Continued progress in this field is essential to advance potential treatments for inflammatory disorders and for developing improved vaccines against mucosal pathogens.
